Related Experiment Videos
Heart rate variability in dilated cardiomyopathy
P K Biswas1, S Basu, K K Mitra
1Department of Cardiology, SSKM Hospital, Calcutta.
Indian Heart Journal
|July 14, 2000
Summary
Heart rate variability (HRV) is significantly reduced in patients with dilated cardiomyopathy, indicating autonomic imbalance. This study highlights HRV as a valuable tool for assessing heart failure severity and prognosis.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Medical Diagnostics
Background:
- Chronic heart failure (CHF) is characterized by excessive neurohormonal activation.
- Heart rate variability (HRV) analysis is a validated method for assessing cardiac autonomic balance.
- Dilated cardiomyopathy (DCM) is a common form of CHF often associated with autonomic dysfunction.
Purpose of the Study:
- To investigate heart rate variability parameters in symptomatic patients with dilated cardiomyopathy.
- To compare HRV in DCM patients with healthy controls.
- To explore the correlation between HRV and clinical parameters like ejection fraction and NYHA class.
Main Methods:
- 24-hour Holter monitoring was performed on 20 DCM patients (NYHA class II-IV) and 20 controls.
- Time-domain (SDNN, 5-min SD, RMSSD) and frequency-domain (LF, HF, Total Power) HRV analyses were conducted.
- Ejection fraction and NYHA class were recorded for correlation analysis.
Main Results:
- DCM patients exhibited significantly higher mean heart rate and lower mean hourly heart rate standard deviation compared to controls.
- Key HRV parameters, including SDNN, 5-min SD, and low-frequency power, were significantly reduced in DCM patients.
- Reduced HRV parameters correlated significantly with decreased ejection fraction and increased NYHA class.
Conclusions:
- Symptomatic dilated cardiomyopathy patients demonstrate significantly impaired heart rate variability compared to healthy individuals.
- HRV parameters are valuable indicators of autonomic imbalance in DCM.
- HRV analysis can aid in assessing disease severity and potentially predicting outcomes in DCM patients.